Case series evaluation: PROMOGRAN™ Protease Modulating Matrix and PROMOGRAN PRISMA™ Wound Balancing Matrix for non-healing wounds

This Wounds International case series evaluation presents seven case studies from five locations, illustrating use of PROMOGRAN Matrix and PROMOGRAN PRISMA Matrix in a range of wounds including diabetic foot wounds, leg ulcers, and atypical ulcers. All the wounds included in this study had stalled wounds, which had failed to heal within the expected timeframe.

​Supported by KCI – An Acelity Company